{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:22:18Z","timestamp":1794540138678,"version":"4.9.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Primary diffuse leptomeningeal melanomatosis (PDLM) is a rare disease that affects melanocytes in the leptomeninges. There is very limited data on the efficacy of immunotherapy in this setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A patient (23\u200ayears old) was diagnosed with PDLM. Histologically, atypical melanocytic cells were also observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis:<\/jats:title>\n                    <jats:p>\n                      Immunohistochemistry showed positivity for S100 protein, NKiC3, and vimentin, and negativity for Melan-A and HMB-45, with a proliferation index of 30%. Extracranial disease was excluded using dermatological and other examinations, including positron emission tomography\/computed tomography with\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient was treated with whole-brain radiotherapy (10 fractions to a total dose of 30\u200aGy) concomitantly with pembrolizumab and then continued with immunotherapy until disease progression with a maximum effect of partial remission on magnetic resonance imaging scans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Progression-free survival was 6.0\u200amonths and overall survival 6.5\u200amonths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This is one of the few case reports of an adult patient with this rare malignancy being treated with a programmed death-1 inhibitor with partial response. Immunotherapy in metastatic PDLM may be a reasonable therapeutic option.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000028613","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T08:00:47Z","timestamp":1642752047000},"page":"e28613","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4505-0952","authenticated-orcid":false,"given":"Patrik","family":"Palacka","sequence":"first","affiliation":[{"name":"2Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia"},{"name":"National Cancer Institute, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Slopovsky","sequence":"additional","affiliation":[{"name":"2Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia"},{"name":"National Cancer Institute, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Makovnik","sequence":"additional","affiliation":[{"name":"2Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia"},{"name":"Department of Radiology, National Cancer Institute, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Kajo","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Elisabeth Cancer Institute, Bratislava, Slovakia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Obertova","sequence":"additional","affiliation":[{"name":"2Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia"},{"name":"National Cancer Institute, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mego","sequence":"additional","affiliation":[{"name":"2Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia"},{"name":"National Cancer Institute, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1200\/JCO.2013.50.0264","article-title":"Primary leptomeningeal melanoma mimicking meningitis: a case report and literature review","volume":"33","author":"Hsieh","year":"2015","journal-title":"J Clin Oncol"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/NRL.0b013e3181c29ef8","article-title":"Primary diffuse meningeal melanomatosis","volume":"16","author":"Zadro","year":"2010","journal-title":"Neurologist"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"e22928","DOI":"10.1097\/MD.0000000000022928","article-title":"Primary leptomeningeal melanomatosis successfully treated with PD-1 inhibitor pembrolizumab: a case report","volume":"99","author":"Krpan","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/jpm11040292","article-title":"Novel insights into diagnosis, biology, and treatment of primary diffuse leptomeningeal melanomatosis","volume":"11","author":"Baumgartner","year":"2021","journal-title":"J Pers Med"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3171\/jns.2001.94.3.0528","article-title":"Cerebrospinal fluid immunocytochemical analysis and neuroimaging in the diagnosis of primary leptomeningeal melanoma. Case report","volume":"94","author":"Tosaka","year":"2001","journal-title":"J Neurosurg"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/2152-7806.142795","article-title":"Primary melanocytic tumors of the central nervous system: report of two cases and review of literature","volume":"5","author":"Trinh","year":"2014","journal-title":"Surg Neurol Int"},{"key":"R7-20250618","article-title":"WHO Classification of Tumours of the Central Nervous System","year":"2007"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/sonc.2002.35247","article-title":"The treatment of brain metastases from malignant melanoma","volume":"29","author":"Douglas","year":"2002","journal-title":"Semin Oncol"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/s12885-016-2556-y","article-title":"NRASQ61K mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications","volume":"16","author":"Angelino","year":"2016","journal-title":"BMC Cancer"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Hussein","year":"2018","journal-title":"N Engl J Med"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10143-017-0914-0","article-title":"Primary central nervous system malignant melanoma with leptomeningeal melanomatosis: a case report and review of the literature","volume":"41","author":"Fujimori","year":"2017","journal-title":"Neurosurg Rev"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.breast.2011.05.007","article-title":"Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis","volume":"20","author":"Mego","year":"2011","journal-title":"Breast"},{"key":"R14-20250618","first-page":"e4446","article-title":"Efficacy of pembrolizumab and nivolumab in crossing the blood brain barrier","volume":"11","author":"Abid","year":"2019","journal-title":"Cureus"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T08:01:18Z","timestamp":1750233678000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028613","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"2021-12-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}